In vivo, oral administration of galangin alleviated colitis, reduced proinflammatory cytokines (TNF-α and IL-6), increased anti-inflammatory IL-10, and decreased MPO, nitrites, and TBARS levels while increasing SOD 137. This evidence concerns the gene MPO and colitis.